Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Antibodies, Protozoan"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 425
Tytuł:
Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine.
Autorzy:
Ma R; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Salinas ND; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Orr-Gonzalez S; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Richardson B; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Ouahes T; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Torano H; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Jenkins BJ; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Dickey TH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Neal J; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Duan J; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Morrison RD; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Gittis AG; Structural Biology Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Doritchamou JYA; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Zaidi I; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Lambert LE; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Duffy PE; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Tolia NH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 04; Vol. 20 (3), pp. e1011879. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Malaria Vaccines*
Malaria, Falciparum*/parasitology
Malaria*
Humans ; Pregnancy ; Female ; Placenta/metabolism ; Antibodies, Protozoan ; Plasmodium falciparum/metabolism ; Antigens, Protozoan ; Chondroitin Sulfates/metabolism ; Erythrocytes/parasitology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Atypical memory B cell frequency correlates with antibody breadth and function in malaria immune adults.
Autorzy:
Partey FD; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. .
Dowuona JNN; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Pobee ANA; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Walker MR; Centre for Medical Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Aculley B; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Prah DA; West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Ghana.
Ofori MF; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Barfod LK; Centre for Medical Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 28; Vol. 14 (1), pp. 4888. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Malaria, Falciparum*/epidemiology
Malaria*
Adult ; Animals ; Humans ; Memory B Cells ; Antigens, Protozoan ; Antibodies, Protozoan ; Plasmodium falciparum ; Merozoites ; Protozoan Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.
Autorzy:
Pourhashem Z; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Nourani L; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Sani JJ; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Yousefi H; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Pirahmadi S; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Sabouri M; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Raz A; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Djadid ND; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
Zakeri S; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran. .
Mehrizi AA; Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2023 Dec 09; Vol. 22 (1), pp. 374. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Malaria Vaccines*
Malaria, Falciparum*
Animals ; Mice ; Adjuvants, Immunologic ; Adjuvants, Pharmaceutic ; Antibodies, Protozoan ; Antigens, CD ; Antigens, Protozoan ; Immunoglobulin G ; Iran ; Oocysts ; Plasmodium falciparum ; Protozoan Proteins/metabolism ; Vaccines, Synthetic ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals.
Autorzy:
Tamborrini M; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Schäfer A; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Hauser J; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Zou L; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Paris DH; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland.; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
Pluschke G; Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123, Allschwil, Switzerland. .; University of Basel, Petersplatz 1, 4001, Basel, Switzerland. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2023 Jul 15; Vol. 22 (1), pp. 210. Date of Electronic Publication: 2023 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
Parasites*
Malaria, Falciparum*/prevention & control
Malaria Vaccines*
Animals ; Mice ; Humans ; Rabbits ; Toll-Like Receptor 4 ; Lipid A ; Plasmodium falciparum ; Adjuvants, Immunologic ; Antigens, Protozoan ; Protozoan Proteins ; Animals, Laboratory ; Adjuvants, Pharmaceutic ; Immunoglobulin G ; Antibodies, Protozoan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites.
Autorzy:
Markwalter CF; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
Petersen JEV; Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina, United States of America.
Zeno EE; Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina, United States of America.; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Sumner KM; Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina, United States of America.; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Freedman E; Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina, United States of America.
Mangeni JN; School of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya.
Abel L; Academic Model Providing Access to Healthcare, Moi Teaching and Referral Hospital, Eldoret, Kenya.
Obala AA; School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
Prudhomme-O'Meara W; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.; Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina, United States of America.; School of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya.
Taylor SM; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.; Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina, United States of America.; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Jun 12; Vol. 19 (6), pp. e1011442. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Parasites*
Malaria*/parasitology
Malaria, Falciparum*/parasitology
Malaria Vaccines*
Animals ; Plasmodium falciparum/metabolism ; Reinfection ; Protozoan Proteins/metabolism ; Antigens, Protozoan ; Epitopes/genetics ; Antibodies, Protozoan/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
Autorzy:
Doritchamou JYA; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.
Renn JP; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.
Hviid L; Centre for Medical Parasitology, Department of Microbiology and Immunology, University of Copenhagen and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 May 25; Vol. 19 (5), pp. e1011370. Date of Electronic Publication: 2023 May 25 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Malaria Vaccines*
Malaria, Falciparum*/prevention & control
Malaria*
Female ; Pregnancy ; Humans ; Placenta/metabolism ; Epitopes/genetics ; Plasmodium falciparum/metabolism ; Antigens, Protozoan ; Antibodies, Protozoan ; Chondroitin Sulfates/metabolism ; Erythrocytes/parasitology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
Autorzy:
Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12735 Twinbrook Parkway, Rockville, MD, 20852, USA. .
Diouf A; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12735 Twinbrook Parkway, Rockville, MD, 20852, USA.
Fay MP; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, 20852, USA.
Barrett JR; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.
Payne RO; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.
Olotu AI; Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.
Minassian AM; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.
Silk SE; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.
Draper SJ; Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK.
Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 12735 Twinbrook Parkway, Rockville, MD, 20852, USA.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2023 May 19; Vol. 22 (1), pp. 159. Date of Electronic Publication: 2023 May 19.
Typ publikacji:
Journal Article
MeSH Terms:
Malaria, Falciparum*/parasitology
Malaria Vaccines*
Humans ; Plasmodium falciparum ; Antibodies, Protozoan ; Erythrocytes/parasitology ; Antibodies, Viral ; Antigens, Protozoan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunological characterization of a VIR protein family member (VIR-14) in Plasmodium vivax-infected subjects from different epidemiological regions in Africa and South America.
Autorzy:
Fantin RF; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.; School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Coelho CH; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Berhe AD; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Magalhães LMD; Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Pereira DB; Center for Research in Tropical Medicine, Porto Velho, Brazil.
Salinas ND; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Tolia NH; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Amaratunga C; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Suon S; National Center for Parasitology, Entomology, and Malaria Control, Phnom Penh, Cambodia.
Sagara I; Faculty of Medicine and Odonto-Stomatology, University of Sciences, Techniques and Technology of Bamako, Bamako, Mali.
Narum DL; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Fujiwara RT; Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Abejon C; DetectoGen Inc., Westborough, Massachusetts, United States of America.
Campos-Neto A; DetectoGen Inc., Westborough, Massachusetts, United States of America.; Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, United States of America.
Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
Bueno LL; Department of Parasitology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Apr 07; Vol. 17 (4), pp. e0011229. Date of Electronic Publication: 2023 Apr 07 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
MeSH Terms:
Malaria, Vivax*/parasitology
Malaria, Falciparum*/epidemiology
Humans ; Plasmodium vivax/genetics ; Protozoan Proteins/genetics ; Antigens, Protozoan ; Plasmodium falciparum ; Antibodies, Protozoan ; Brazil/epidemiology ; Family ; Immunoglobulin G ; Mali/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Retrospective study of toxoplasmosis prevalence in pregnant women in Benin and its relation with malaria.
Autorzy:
Dambrun M; Université de Paris, MERIT, IRD, Paris, France.
Dechavanne C; Université de Paris, MERIT, IRD, Paris, France.
Guigue N; Service de Microbiologie, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Paris, France.
Briand V; Université de Paris, MERIT, IRD, Paris, France.
Candau T; Service de Parasitologie, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Bichat Claude-Bernard, Paris, France.
Fievet N; Université de Paris, MERIT, IRD, Paris, France.
Lohezic M; Université de Paris, MERIT, IRD, Paris, France.
Manoharan S; Université de Paris, MERIT, IRD, Paris, France.
Sare N; Institut de Recherche Clinique du Bénin, Cotonou, Bénin.
Viwami F; Institut de Recherche Clinique du Bénin, Cotonou, Bénin.
Simon F; Service de Microbiologie, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Paris, France.
Houzé S; Université de Paris, MERIT, IRD, Paris, France.; Service de Parasitologie, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Bichat Claude-Bernard, Paris, France.
Migot-Nabias F; Université de Paris, MERIT, IRD, Paris, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jan 07; Vol. 17 (1), pp. e0262018. Date of Electronic Publication: 2022 Jan 07 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Pregnant Women*
Antibodies, Protozoan/*blood
Malaria, Falciparum/*epidemiology
Plasmodium falciparum/*isolation & purification
Pregnancy Complications, Parasitic/*epidemiology
Toxoplasma/*isolation & purification
Toxoplasmosis/*epidemiology
Adolescent ; Adult ; Antibodies, Protozoan/immunology ; Benin/epidemiology ; Female ; Humans ; Infant, Newborn ; Malaria, Falciparum/blood ; Malaria, Falciparum/parasitology ; Pregnancy ; Pregnancy Complications, Parasitic/parasitology ; Retrospective Studies ; Seroepidemiologic Studies ; Toxoplasmosis/blood ; Toxoplasmosis/parasitology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire.
Autorzy:
Kucharska I; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
Binter Š; Kymab Ltd., The Bennet Building (B930) Babraham Research Campus, Cambridge, United Kingdom.
Murugan R; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
Scally SW; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
Ludwig J; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
Prieto K; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
Thai E; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Costa G; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
Li K; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
Horn GQ; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
Flores-Garcia Y; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Bosch A; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
Sicard T; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
Rubinstein JL; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Zavala F; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Dennison SM; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
Tomaras GD; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
Levashina EA; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
Kellam P; Kymab Ltd., The Bennet Building (B930) Babraham Research Campus, Cambridge, United Kingdom.; Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.
Wardemann H; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
Julien JP; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Nov 28; Vol. 18 (11), pp. e1010999. Date of Electronic Publication: 2022 Nov 28 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria, Falciparum*/parasitology
Malaria*/parasitology
Malaria Vaccines*
Humans ; Mice ; Animals ; Plasmodium falciparum ; Cryoelectron Microscopy ; Protozoan Proteins ; Mice, Transgenic ; Antibodies, Monoclonal ; Antibodies, Protozoan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area.
Autorzy:
Tassi Yunga S; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, Bioscience Building Suite 320, Honolulu, HI, 96813, USA. .; Cancer Early Detection Advanced Research Center (CEDAR), School of Medicine, Knight Cancer Institute, Oregon Health & Science University, 2720 S. Moody Avenue, Portland, OR, USA. .
Siriwardhana C; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, MEB411, Honolulu, HI, 96813, USA.
Fouda GG; Department of Pediatrics, Joan & Sanford I. Weill Medical College of Cornell University, New York, NY, USA.
Bobbili N; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, Bioscience Building Suite 320, Honolulu, HI, 96813, USA.
Sama G; The Biotechnology Center, University of Yaoundé 1, Messa, BP 3851, Yaoundé, Cameroon.
Chen JJ; Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, MEB411, Honolulu, HI, 96813, USA.
Leke RFG; The Biotechnology Center, University of Yaoundé 1, Messa, BP 3851, Yaoundé, Cameroon.
Taylor DW; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, Bioscience Building Suite 320, Honolulu, HI, 96813, USA. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2022 Nov 19; Vol. 21 (1), pp. 346. Date of Electronic Publication: 2022 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Malaria, Falciparum*/epidemiology
Malaria*
Humans ; Infant ; Adult ; Plasmodium falciparum ; Antibodies, Protozoan ; Merozoite Surface Protein 1 ; Antibody Formation ; Antigens, Protozoan ; Immunoglobulin M ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.
Autorzy:
Raghavan SSR; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Dagil R; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Lopez-Perez M; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Conrad J; Swedish National Cryo-EM Facility, Science for Life Laboratories, Solna, Sweden.
Bassi MR; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Quintana MDP; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Choudhary S; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Gustavsson T; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Wang Y; Joint Research Centre for Engineering Biology, Zhejiang University-University of Edinburgh Institute, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Gourdon P; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Ofori MF; Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Christensen SB; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Minja DTR; National Institute for Medical Research, Tanga Centre, Tanga, Tanzania.
Schmiegelow C; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Nielsen MA; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Barfod L; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Hviid L; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Salanti A; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Lavstsen T; Centre for Medical Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Wang K; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Nov 16; Vol. 18 (11), pp. e1010924. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Malaria, Falciparum*/parasitology
Malaria*
Humans ; Female ; Pregnancy ; Antigens, Protozoan ; Epitopes ; Antibodies, Protozoan ; Antibodies, Monoclonal ; Cryoelectron Microscopy ; Placenta/metabolism ; Plasmodium falciparum/metabolism ; Erythrocytes/parasitology ; Chondroitin Sulfates/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design.
Autorzy:
Shukla N; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.
Tang WK; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.
Tolia NH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 15; Vol. 12 (1), pp. 19556. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Malaria Vaccines*
Malaria, Falciparum*/prevention & control
Malaria, Vivax*
Malaria*
Animals ; Plasmodium falciparum ; Epidermal Growth Factor ; Protozoan Proteins ; Antigens, Protozoan ; Antigens, Surface ; Antibodies, Protozoan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.
Autorzy:
Mangou K; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Moore AJ; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Thiam LG; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Ba A; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Orfanó A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Desamours I; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Ndegwa DN; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; University of Embu, Embu, Kenya.
Goodwin J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Guo Y; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Sheng Z; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Patel SD; Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA.
Diallo F; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Sene SD; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Pouye MN; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Faye AT; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Thiam A; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Nunez V; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Diagne CT; MIVEGEC (Infectious Diseases and Vector: Ecology, Genetics, Evolution and Control), University of Montpelier, IRD, CNRS, Montpellier, France.
Sadio BD; Pôle Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Shapiro L; Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA.; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.; Department of Biochemistry and Biophysics, Columbia University, New York, NY, USA.
Faye O; Pôle Virologie, Institut Pasteur de Dakar, Dakar, Senegal.
Mbengue A; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal.
Bei AK; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. .; G4 - Malaria Experimental Genetic Approaches & Vaccines, Pôle Immunophysiopathologie et Maladies Infectieuses, Institut Pasteur de Dakar, Dakar, Senegal. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 12; Vol. 12 (1), pp. 19403. Date of Electronic Publication: 2022 Nov 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Malaria Vaccines*/genetics
Malaria, Falciparum*/prevention & control
Humans ; Plasmodium falciparum/metabolism ; Antibodies, Protozoan ; Antigens, Protozoan/genetics ; Carrier Proteins/metabolism ; Protozoan Proteins/genetics ; Protozoan Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term.
Autorzy:
Kayatani AKK; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, Bioscience Building, Honolulu, HI, 96813, USA.
Leke RGF; Faculty of Medicine & Biomedical Sciences, The Biotechnology Center, University of Yaoundé 1, Messa, BP 3851, Yaoundé, Cameroon.
Leke RIJ; Faculty of Medicine & Biomedical Sciences, The Biotechnology Center, University of Yaoundé 1, Messa, BP 3851, Yaoundé, Cameroon.
Fogako J; Faculty of Medicine & Biomedical Sciences, The Biotechnology Center, University of Yaoundé 1, Messa, BP 3851, Yaoundé, Cameroon.
Taylor DW; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, Bioscience Building, Honolulu, HI, 96813, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 07; Vol. 12 (1), pp. 18864. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Plasmodium falciparum*
Malaria, Falciparum*
Infant, Newborn ; Infant ; Female ; Humans ; Pregnancy ; Immunoglobulin G ; Immunity, Maternally-Acquired ; Antigens, Protozoan ; Antibodies, Protozoan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sporozoite motility as a quantitative readout for anti-CSP antibody inhibition.
Autorzy:
de Korne CM; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
van Schuijlenburg R; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Sijtsma JC; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
de Bes HM; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Baalbergen E; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Azargoshasb S; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
van Oosterom MN; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
McCall MBB; Department of Medical Microbiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
van Leeuwen FWB; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Roestenberg M; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Oct 13; Vol. 12 (1), pp. 17194. Date of Electronic Publication: 2022 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Malaria*/prevention & control
Malaria Vaccines*
Malaria, Falciparum*
Animals ; Antibodies, Monoclonal/pharmacology ; Antibodies, Protozoan ; Humans ; Membrane Proteins ; Plasmodium falciparum ; Protozoan Proteins ; Sporozoites
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01 E vaccination and seasonal malaria chemoprevention versus either intervention given alone.
Autorzy:
Cairns M; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. .
Barry A; Malaria Research and Training Centre, Bamako, Mali.
Zongo I; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Sagara I; Malaria Research and Training Centre, Bamako, Mali.
Yerbanga SR; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Diarra M; Malaria Research and Training Centre, Bamako, Mali.
Zoungrana C; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Issiaka D; Malaria Research and Training Centre, Bamako, Mali.
Sienou AA; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Tapily A; Malaria Research and Training Centre, Bamako, Mali.
Sanogo K; Malaria Research and Training Centre, Bamako, Mali.
Kaya M; Malaria Research and Training Centre, Bamako, Mali.
Traore S; Malaria Research and Training Centre, Bamako, Mali.
Diarra K; Malaria Research and Training Centre, Bamako, Mali.
Yalcouye H; Malaria Research and Training Centre, Bamako, Mali.
Sidibe Y; Malaria Research and Training Centre, Bamako, Mali.
Haro A; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Thera I; Malaria Research and Training Centre, Bamako, Mali.
Snell P; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Grant J; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Tinto H; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Milligan P; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Chandramohan D; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Greenwood B; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Dicko A; Malaria Research and Training Centre, Bamako, Mali.
Ouedraogo JB; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Oct 07; Vol. 20 (1), pp. 352. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria*/epidemiology
Malaria*/prevention & control
Malaria Vaccines*
Malaria, Falciparum*/epidemiology
Antibodies, Protozoan ; Chemoprevention ; Humans ; Infant ; Plasmodium falciparum ; Seasons ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Understanding the role of serological and clinical data on assessing the dynamic of malaria transmission: a case study of Bagamoyo district, Tanzania.
Autorzy:
Mwamlima TG; Ifakara Health Institute, Bagamoyo, Tanzania.; Department of Life Science and Bio-Engineering, The Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
Mwakasungula SM; Ifakara Health Institute, Bagamoyo, Tanzania.
Mkindi CG; Ifakara Health Institute, Bagamoyo, Tanzania.
Tambwe MM; Ifakara Health Institute, Bagamoyo, Tanzania.
Mswata SS; Ifakara Health Institute, Bagamoyo, Tanzania.
Mbwambo SG; Ifakara Health Institute, Bagamoyo, Tanzania.
Mboya MF; Amref Health Africa-Tanzania, Dar es Salaam, Tanzania.
Draper SJ; Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom.
Silk SE; Amref Health Africa-Tanzania, Dar es Salaam, Tanzania.
Mpina MG; Ifakara Health Institute, Bagamoyo, Tanzania.
Vianney JM; Department of Life Science and Bio-Engineering, The Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
Olotu AI; Ifakara Health Institute, Bagamoyo, Tanzania.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2022 Oct 07; Vol. 43, pp. 60. Date of Electronic Publication: 2022 Oct 07 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Malaria, Falciparum*/epidemiology
Malaria Vaccines*
Malaria*/epidemiology
Infant ; Humans ; Tanzania/epidemiology ; Cross-Sectional Studies ; Immunoglobulin G ; Antibodies, Protozoan ; Plasmodium falciparum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Plasmodium falciparum serology: A comparison of two protein production methods for analysis of antibody responses by protein microarray.
Autorzy:
Oulton T; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Obiero J; Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, United States of America.
Rodriguez I; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Ssewanyana I; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University College of Health Sciences, Kampala, Uganda.
Dabbs RA; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Bachman CM; Global Health Labs, Inc, Bellevue, Washington, United States of America.
Greenhouse B; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Drakeley C; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Felgner PL; Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, United States of America.
Stone W; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Tetteh KKA; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 29; Vol. 17 (8), pp. e0273106. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria, Falciparum*
Plasmodium falciparum*
Antibodies, Protozoan ; Antibody Formation ; Antigens, Protozoan ; Biomarkers/metabolism ; Humans ; Protein Array Analysis ; Proteomics ; Recombinant Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 425

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies